First Citizens BancShares
FCNCA
$2324.24
+0.28%
First Citizens BancShares is a Raleigh, North Carolina-based regional bank holding company with roughly $237 billion in total assets, operating retail, commercial, wealth management, and railcar leasing businesses concentrated in North Carolina, South Carolina, and California. The bank is best known for its opportunistic FDIC-assisted acquisitions of troubled institutions — most notably Silicon Valley Bridge Bank in 2023, which roughly doubled its asset base and transformed it into a super-regional player with a distinctive, acquisition-driven growth model. The current investor debate centers on whether First Citizens can convert the windfall economics of the SVB deal into durable, organic earnings power, with attention on net interest margin resilience, credit quality in its commercial real estate and venture-lending books, and the pace of an aggressive share repurchase program that has shrunk the share count meaningfully. Recent quarterly results showed sequential EPS growth and margin expansion, but essentially flat year-over-year revenue, keeping the narrative balanced between capital-return-driven value and concerns about organic growth stagnation.…
FCNCA
First Citizens BancShares
$2324.24
Investment Opinion: Should I buy FCNCA Today?
Rating: Hold. First Citizens is a capital-return-driven value stock whose per-share earnings engine — a 17% share-count reduction from 13.58 million to 11.25 million diluted shares over the past year — is doing nearly all the work while revenue sits flat at 0.14% YoY growth ($3.699 billion vs. $3.694 billion). The analyst stance is neutral-to-cautious: of ten ratings only one is a Buy (TD Cowen), five are Neutral/Hold, and JP Morgan downgraded to Underweight on October 26 right after the Q3 print; no average price target is disclosed, so the thesis must be anchored on the lone quantitative EPS estimate of $231.56, which implies roughly 9.8x forward earnings at $2,273.74.
Supporting evidence is genuinely mixed but leans toward fair value rather than opportunity. On the positive side, EPS rose 18.8% YoY to $51.23 despite flat revenue, gross margin expanded to 64.29% from 60.61%, TTM free cash flow of $2.301 billion comfortably funds roughly $3.0 billion of annual repurchases ($600 million in Q3 alone), and the stock has outperformed SPY by 16.71 percentage points over the trailing year (26.30% vs. 9.59%). Against that, ROE of 9.92% sits below the 12-15% threshold that justifies a premium bank multiple, the 1.19x price-to-book already embeds some improvement, trailing PE of 12.95x sits in the middle-to-upper portion of a historical 6.8x-17.2x band, and Q3 net income fell sequentially to $606 million from $672 million as operating margin compressed to 21.76% from 24.72%. The 0.61% dividend yield with a 7.3% payout ratio confirms this is not an income vehicle.
Three risks could invalidate the thesis: a slowdown in the buyback pace (which would expose the flat revenue line), margin compression from deposit repricing, and credit deterioration in the commercial real estate and venture-lending books inherited from SVB. This Hold would upgrade to Buy if the forward multiple compressed toward 8x on a stable or rising EPS base, or if revenue growth turned positive and ROE moved toward 12%; it would downgrade to Sell if revenue growth stayed near zero while credit costs rose and the buyback slowed, or if the stock broke below the $2,196 gap-fill level toward the $1,909.53 180-day low. Net verdict: fairly valued, not cheap — the market is paying a mid-cycle multiple for a bank with flat revenue and a finite buyback lever.
Sign up to view all
FCNCA 12-Month Price Forecast
First Citizens is a fairly valued, capital-return-driven value stock rather than a growth story: the buyback machine is genuinely powerful, but it is masking a completely flat revenue base and a sequential Q3 earnings decline. The roughly 9.8x forward multiple and 1.19x book are undemanding for a $237 billion-asset super-regional with a 9.92% ROE, but they are not cheap enough to compensate for thin coverage, a fresh Underweight rating, and the -19.86% max drawdown that shows sharp air pockets occur even within the uptrend. The single variable that matters most is durability of the post-SVB earnings base — if net interest margin and credit hold, the buyback compounds value at a mid-cycle multiple; if margins compress or credit costs rise, the flat top line leaves nothing to absorb the hit. I would upgrade to bullish on a decisive break above $2,382.50 accompanied by positive revenue growth or ROE moving toward 12%, and downgrade to bearish on a break below the $2,196 gap-fill level or evidence of rising credit provisions.
Wall Street consensus
Coverage is thin, with only 1 analyst contributing to the quantitative estimate set, which limits the reliability of consensus figures. That lone estimate projects EPS of $231.56 (range $228.06 to $235.36) on revenue of $9.98 billion (range $9.86 billion to $10.10 billion), implying roughly 9.8x forward earnings at the current price — a multiple that suggests the estimate embeds continued buyback-driven EPS growth. The qualitative institutional ratings are more informative: across the ten ratings shown, the distribution is one Buy (TD Cowen), five Neutral/Equal Weight/Hold (Citigroup, Barclays, Truist, Piper Sandler, and JP Morgan's October 1 Neutral), and one Underweight (JP Morgan, downgraded from Neutral on October 26) — a distinctly neutral-to-cautious tilt with no strong bullish conviction. No average price target is provided in the data, so implied upside cannot be calculated; the consensus stance should be characterized as neutral, with the notable negative signal being JP Morgan's downgrade to Underweight immediately following the October 26 print. The target range implied by the EPS estimates ($228.06 low to $235.36 high) is tight — a spread of only about 3.2% — which normally signals high conviction, but with a single contributor this tightness reflects a single model rather than broad agreement. The high-end estimate assumes continued margin expansion and aggressive repurchases sustaining double-digit EPS growth, while the low end implies modest margin compression or slower buyback activity; the more meaningful dispersion is in the ratings, where the gap between TD Cowen's Buy and JP Morgan's Underweight reflects genuine disagreement about whether the post-SVB earnings base is durable. Insufficient analyst coverage — one quantitative estimate and a handful of ratings — is typical of a high-share-price, low-float regional bank with limited retail and index participation, and it implies wider bid-ask spreads, higher volatility around earnings, and less efficient price discovery, all of which argue for demanding a valuation discount rather than paying a premium.
Drowning in data?
Find the real signal!
Bulls vs Bears: FCNCA Investment Factors
The bear case currently has slightly stronger near-term evidence: revenue is flat at 0.14% YoY growth, Q3 earnings fell sequentially, and the analyst community is tilted neutral-to-cautious with a fresh Underweight from JP Morgan. The bull case rests on a genuinely powerful buyback lever — a 17% share-count reduction driving 18.8% EPS growth — plus margin expansion and strong relative momentum, but those are capital-allocation and cost stories rather than growth stories. The single most important tension is whether the post-SVB earnings base is durable: if net interest margin and credit quality hold, the ~9.8x forward multiple and 1.19x book are undemanding and the buyback compounds value; if margins compress or credit costs rise in commercial real estate or venture lending, the flat revenue line leaves nothing to absorb the hit. On balance, this is a fairly valued, capital-return-driven value stock with a neutral risk/reward at current prices near the top of its range.
Bullish
- Buyback machine shrinking share count fast: Diluted shares fell from 13.58 million in Q3 2025 to 11.25 million in Q3 2026, a roughly 17% reduction, with $600 million repurchased in Q3 alone and about $3.0 billion over the trailing four quarters. This mechanical shrink drove EPS from $43.12 to $51.23 year over year (+18.8%) even though revenue was flat, and the $2.301 billion TTM free cash flow comfortably funds the program.
- Margin expansion and improving profitability: Gross margin rose to 64.29% in Q3 2026 from 60.61% in Q3 2025, and net margin improved to 16.38% from 15.35% in Q1 2026. Net income of $606 million was up from $568 million a year earlier despite essentially flat revenue, showing the SVB-era cost and funding structure is being squeezed for efficiency.
- Strong relative momentum versus the market: FCNCA is up 26.30% over the trailing year versus 9.59% for SPY, a 16.71 percentage point relative strength advantage, and gained 9.76% in the past month while SPY fell 4.99% (14.75 points of relative strength). The stock sits near the top of its 180-day range at $2,273.74 versus a $2,382.50 high, confirming a persistent uptrend.
- Reasonable valuation at 1.19x book: The 1.19x price-to-book and 12.95x trailing PE are mid-cycle multiples for a super-regional bank, and the analyst EPS estimate of $231.56 implies roughly 9.8x forward earnings. With a 9.92% ROE, the modest premium to book looks fair rather than stretched, leaving room for multiple support if earnings hold.
Bearish
- Revenue has completely flatlined: Q3 2026 revenue of $3.699 billion grew just 0.14% year over year versus $3.694 billion, and the prior four quarters ranged narrowly from $3.525 billion to $3.694 billion. The SVB acquisition tailwind has fully annualized, leaving no organic top-line growth to support the story beyond buybacks and margin management.
- Sequential earnings deterioration in Q3: Net income fell to $606 million in Q3 from $672 million in Q2, and operating income dropped to $805 million from $891 million, compressing the operating margin to 21.76% from 24.72%. The trend is not monotonic, and the Q3 print that preceded JP Morgan's downgrade to Underweight showed the earnings base is not reliably rising.
- Analyst sentiment is neutral-to-negative: Of ten ratings, only one is a Buy (TD Cowen), five are Neutral/Hold, and one is Underweight after JP Morgan downgraded from Neutral on October 26, immediately following the Q3 print. Coverage is thin with a single quantitative estimate, which widens bid-ask spreads and reduces price discovery efficiency.
- ROE below premium-bank thresholds: ROE of 9.92% sits below the 12-15% range investors typically demand of a premium regional bank, and the 1.19x book multiple already prices in some improvement. If ROE stays near 10%, the valuation has limited room to expand and book value growth depends on retained earnings that are being diverted to buybacks.
FCNCA Technical Analysis
First Citizens is in a sustained uptrend, with the stock up 26.30% over the trailing year versus a 9.59% gain for SPY, a relative strength advantage of 16.71 percentage points. At the current price of $2,273.74, the stock sits roughly 96% of the way through its 180-day range (approximately $1,909.53 low to $2,382.50 high), positioning it near the top of its range — a sign of persistent momentum but also elevated vulnerability to profit-taking. The maximum drawdown of -19.86% over the period shows the stock is capable of sharp air pockets even within a broader advance, so the near-highs positioning should be treated as momentum confirmation rather than a low-risk entry. Short-term momentum is strongly positive and accelerating: the stock gained 9.76% over the past month and 2.49% over three months, with the one-month figure far outpacing the three-month figure, indicating a fresh leg higher rather than a fading trend. This is corroborated by relative strength of 14.75 points versus SPY over the past month (SPY fell 4.99% while FCNCA rallied), a clear sign of defensive rotation into the name. The most striking technical event is the gap from $2,196.76 on October 22 to $2,375.84 on October 23 — a roughly 8.1% single-session surge, likely tied to the November 6 earnings filing — which created a large unfilled gap and a new support shelf in the $2,196-$2,200 zone. Key resistance sits at the $2,382.50 high; a decisive breakout would confirm the uptrend and open blue-sky territory, while a breakdown below the $2,196 gap-fill level would signal exhaustion and likely target the $2,060-$2,100 consolidation zone from September. With volume of just 91,658 shares (thin for a $26.5 billion market cap, reflecting the stock's high per-share price and limited float turnover), moves can be exaggerated; beta is not available in the provided data, but the -19.86% max drawdown and 8% single-day gap imply volatility well above the market average, warranting conservative position sizing.
Beta
—
—
Max Drawdown
-19.9%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+27.4%
Cumulative gain past year
| Period | FCNCA Return | S&P 500 |
|---|---|---|
| 1m | +13.1% | -2.0% |
| 3m | +1.4% | -2.8% |
| 6m | +20.5% | +2.1% |
| 1y | +27.4% | +12.3% |
| ytd | +7.7% | +10.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FCNCA Fundamental Analysis
Revenue has effectively flatlined: Q3 2026 revenue of $3.699 billion grew just 0.14% year over year versus $3.694 billion in Q3 2025, and the multi-quarter trend shows a plateau — $3.478 billion in Q1 2026, $3.604 billion in Q2, and $3.699 billion in Q3, with the prior four quarters ranging from $3.525 billion to $3.694 billion. The sequential improvement is real but modest, and the flat YoY comparison suggests the SVB acquisition tailwind has fully annualized, leaving the bank dependent on net interest margin and fee income rather than balance-sheet expansion. Segment data shows a fee base dominated by deposit fees and service charges ($76 million), asset management ($62 million), and card fees ($40 million), with railcar leasing now under 5% of earnings — a diversified but slow-growing mix that implies the investment case rests on capital return and margin management rather than top-line acceleration. Profitability is solid and improving: Q3 2026 net income was $606 million with a 16.38% net margin, up from $534 million and a 15.35% margin in Q1 2026, while gross margin of 64.29% compares favorably to the 62.13% posted in Q4 2025. However, the trend is not monotonic — Q2 2026 net income of $672 million (18.65% margin) was the peak, and Q3 slipped sequentially as operating income fell to $805 million from $891 million, with the operating margin compressing to 21.76% from 24.72%. EPS nonetheless rose to $51.23 in Q3 from $42.63 in Q1, aided by a shrinking share count (11.25 million diluted shares versus 13.58 million a year earlier), which is doing much of the heavy lifting on per-share metrics. Balance-sheet leverage is typical for a regional bank but elevated in absolute terms: debt-to-equity of 1.62x, an equity multiplier above 10x, and a current ratio of just 1.03 reflect the deposit-funded model. Positively, TTM free cash flow of $2.301 billion and Q3 operating cash flow of $902 million comfortably fund the buyback — $600 million repurchased in Q3 alone and roughly $3.0 billion over the trailing four quarters — while ROE of 9.92% is respectable but below the 12-15% range investors typically demand of a premium regional bank. The dividend is token-sized (0.61% yield, 7.3% payout ratio), confirming that capital return is overwhelmingly channeled through repurchases, which supports EPS but leaves book value growth dependent on retained earnings.
Quarterly Revenue
$3.7B
2026-09
Revenue YoY Growth
+0.1%
YoY Comparison
Gross Margin
64.3%
Latest Quarter
Free Cash Flow
$2.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FCNCA Overvalued?
Because net income is positive ($606 million in Q3), the PE ratio is the appropriate primary metric. The stock trades at 12.95x trailing earnings, but the forward PE of -1.04x is a data anomaly (the negative PEG ratio of -1.04 and forward PE of -1.04x appear to be corrupted or mis-signed fields) and should be disregarded; the analyst consensus EPS estimate of $231.56 implies a far more sensible forward multiple of roughly 9.8x at the current $2,273.74 price, suggesting the market expects earnings growth that would compress the multiple. That gap between 12.95x trailing and ~9.8x forward implies the consensus is pricing in meaningful EPS expansion — consistent with the buyback-driven per-share growth trajectory — but investors should treat the negative forward PE field as unreliable rather than as a signal of expected losses. On peer comparison, the 1.19x price-to-book is the most telling metric: regional banks of this scale typically trade between 1.0x and 1.5x tangible book depending on profitability, and FCNCA's 9.92% ROE sits at the lower end of what justifies a premium, so the modest premium to book looks fair rather than stretched. The 12.95x trailing PE versus a historical band that has ranged from roughly 6.8x (Q3 2023) to 17.2x (Q4 2021) places the stock in the middle-to-upper portion of its own range, while the 1.83x PS ratio compares to a historical range of roughly 5.3x-17.3x on the older, pre-SVB share base — a comparison distorted by the 2023 balance-sheet transformation and therefore of limited use. The 12.42x EV/EBITDA and 9.08x price-to-cash-flow are unremarkable for a bank, and the 0.61% dividend yield with a 7.3% payout ratio confirms the stock is a capital-appreciation and buyback story, not an income vehicle. Net-net, valuation is reasonable but not cheap: the market is paying a mid-cycle multiple for a bank with flat revenue, improving but cyclical margins, and an aggressive but finite buyback lever.
PE
12.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~13x
vs. Industry Avg
12.0x
Industry PE ~12.0x*
EV/EBITDA
12.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the flat revenue base and the reliance on buybacks to generate per-share growth. Q3 2026 revenue of $3.699 billion grew only 0.14% year over year, and net income fell sequentially to $606 million from $672 million as operating income dropped to $805 million from $891 million, compressing the operating margin to 21.76% from 24.72%. The 17% share-count reduction from 13.58 million to 11.25 million diluted shares is doing most of the EPS work, so any slowdown in the roughly $3.0 billion annual repurchase pace would expose the underlying stagnation. Balance-sheet leverage is elevated at 1.62x debt-to-equity with an equity multiplier above 10x and a current ratio of just 1.03, typical for a deposit-funded bank but leaving little buffer if credit costs rise in the commercial real estate and venture-lending books inherited from SVB.
Market and competitive risks include valuation compression and thin, skeptical analyst coverage. At 12.95x trailing earnings and 1.19x book, the stock trades in the middle-to-upper portion of its historical 6.8x-17.2x PE band, so a re-rating toward the low end would be painful; the 9.92% ROE is below the 12-15% level that justifies a premium multiple. Coverage is limited to one quantitative estimate and a handful of ratings, with JP Morgan downgrading to Underweight on October 26 right after the Q3 print, and the stock's high per-share price and low float turnover (91,658 shares traded) mean wider spreads and exaggerated moves. Beta is not available in the data, but the -19.86% max drawdown and 8.1% single-day gap imply volatility well above the market average, and the stock's defensive rally (up 9.76% in a month when SPY fell 4.99%) could reverse sharply if sector rotation turns.
In a worst-case scenario, margin compression from deposit repricing combines with rising credit losses in commercial real estate and venture lending, forcing the bank to slow buybacks just as revenue stays flat — the EPS growth engine stalls and the multiple compresses toward the low end of its historical band. A retest of the 180-day low of $1,909.53 would represent roughly -16% from the current $2,273.74, and a full repeat of the -19.86% max drawdown would take the stock to approximately $1,822, about -20%. A more severe outcome, where credit deterioration forces a dividend or buyback cut and the stock trades toward the 6.8x historical low multiple on a lower earnings base, could produce losses of 25-30% from current levels.
FAQ
Ranked by severity: first, financial/operational risk — revenue grew just 0.14% YoY to $3.699 billion, so the entire EPS story depends on the roughly $3.0 billion annual buyback; any slowdown exposes the stagnation, and operating margin already compressed to 21.76% from 24.72% sequentially. Second, credit risk in the SVB-inherited commercial real estate and venture-lending books — rising provisions would hit a bank with a 1.62x debt-to-equity ratio and an equity multiplier above 10x. Third, valuation and sentiment risk — at 12.95x trailing earnings within a 6.8x-17.2x historical band, a re-rating toward the low end on a lower earnings base implies 25-30% downside, compounded by thin coverage (one quantitative estimate) and JP Morgan's Underweight downgrade. Fourth, market/liquidity risk — the -19.86% max drawdown and an 8.1% single-session gap on October 23 show sharp air pockets, and volume of just 91,658 shares exaggerates moves in either direction.
The base case carries 50% probability with a $2,100-$2,382.50 range, assuming revenue stays near $3.6-$3.7 billion per quarter while buybacks and modest margin management sustain high-single-digit to low-double-digit EPS growth, consistent with the $231.56 consensus implying about 9.8x forward earnings. The bull case (25%) targets $2,382.50-$2,600 on net interest margin expansion, benign credit, continued $600 million-plus quarterly repurchases, and a decisive breakout above the $2,382.50 high. The bear case (25%) targets $1,822-$1,960 if deposit repricing compresses margins and credit losses rise, forcing a buyback slowdown — a retest of the $1,909.53 low is about -16% and a full repeat of the -19.86% drawdown implies roughly $1,822. The base case is most likely, and its key assumption is that the post-SVB earnings base holds so the buyback keeps compounding per-share value at a mid-cycle multiple.
FCNCA looks fairly valued, not cheap. The 12.95x trailing PE sits in the middle-to-upper portion of a historical band that has ranged from roughly 6.8x to 17.2x, and the 1.19x price-to-book is a modest premium that is roughly justified by a 9.92% ROE — below the 12-15% level that would support a richer multiple. The analyst consensus EPS of $231.56 implies about 9.8x forward earnings, meaning the market is already pricing in continued buyback-driven EPS expansion; the negative forward PE and PEG fields in the data are anomalies and should be disregarded. The 12.42x EV/EBITDA and 9.08x price-to-cash-flow are unremarkable for a bank, and the 1.83x PS ratio is distorted by the 2023 SVB balance-sheet transformation. Net-net, the market is paying a mid-cycle multiple for flat revenue and a finite buyback lever, leaving limited margin of safety but no obvious overvaluation.
The risk/reward is balanced rather than compelling at $2,273.74. On the positive side, EPS grew 18.8% YoY to $51.23 on a 17% share-count reduction, gross margin expanded to 64.29% from 60.61%, and the stock has beaten SPY by 16.71 percentage points over the trailing year. Against that, revenue is flat at 0.14% growth, Q3 net income fell sequentially to $606 million from $672 million, and the analyst tilt is one Buy, five Neutral/Hold, and one Underweight after JP Morgan's October 26 downgrade. The biggest downside risk is a margin-compression and credit scenario that could take the stock roughly 16-20% lower toward the $1,909.53 180-day low or the ~$1,822 max-drawdown level. It is a reasonable buy for value investors seeking buyback-driven per-share compounding at a mid-cycle multiple, but only with conservative sizing and preferably on a pullback toward the $2,196 gap-fill support rather than near the $2,382.50 high.
FCNCA is better suited to a long-term hold than to short-term trading. It is a mature, late-stage super-regional bank whose growth comes from capital return rather than expansion — revenue is flat at 0.14% YoY and the 0.61% dividend yield with a 7.3% payout ratio means total return depends on buyback-driven EPS growth and multiple stability over time. Short-term trading is hampered by thin liquidity (91,658 shares daily), an 8.1% single-session gap on October 23, and a -19.86% max drawdown that can punish momentum entries near the $2,382.50 high. Earnings visibility is moderate given limited analyst coverage and exposure to net interest margin and credit cycles. A suggested minimum holding period of 12-24 months allows at least four to eight quarters of buyback compounding to work through the share count, with position sizing kept conservative and entry preferably near the $2,196 gap-fill support.

